Assessing the shift of radiobiological metrics in lung radiotherapy plans using 2D gamma index
|
|
- Ernest Dwight George
- 5 years ago
- Views:
Transcription
1 Original Article Assessing the shift of radiobiological metrics in lung radiotherapy plans using 2D gamma index Abdulhamid Chaikh, Jacques Balosso,2 Department of Radiation Oncology and Medical Physics, University Hospital of Grenoble, Grenoble, France; 2 University of Grenoble Alpes, France Contributions: (I) Conception and design: A Chaikh; (II) Administrative support: J Balosso; (III) Provision of study materials or patients: A Chaikh; (IV) Collection and assembly of data: A Chaikh; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Abdulhamid Chaikh. Department of Radiation Oncology and Medical Physics, University Hospital of Grenoble, Grenoble, France. abdulhamedc@yahoo.com. Background: The purpose of this work is to investigate the 2D gamma (γ) maps to illustrate the change of radiobiological outcomes for lung radiotherapy plans and evaluate the correlation between tumor control probability (TCP), normal tissue complication probability (NTCP) with γ passing rates (γ-rates). Methods: Nine patients with lung cancer were used. The doses were calculated using Modified Batho method integrated with pencil beam convolution (MB-PBC) and anisotropic analytical algorithm (AAA) using the same beam arrangements and prescription dose. The TCP and NTCP were estimated, respectively, using equivalent uniform dose (EUD) model and Lyman-Kutcher-Burman (LKB) model. The correlation between ΔTCP or ΔNTCP with γ-rates, from 2%/2 and 3%/3 mm, were tested to explore the best correlation predicting the relevant γ criteria using Spearman s rank test (ρ). Wilcoxon paired test was used to calculate P value. Results: TCP value was significantly lower in the recalculated AAA plans as compared to MB plans. However, AAA predicted more NTCP on lung pneumonitis according to the LKB model and using relevant radiobiological parameters (n, m and TD5) for MB-PBC and AAA, with P=.3. The data showed a weak correlation between radiobiological metrics with γ-rates or γ-mean, ρ<.3. Conclusions: AAA and MB yield different TCP values as well as NTCP for lung pneumonitis based on the LKB model parameters. Therefore, 2D γ-maps, generated with 2%/2 or 3%/3 mm, could illustrate visual information about the radiobiological changes. The information is useful to evaluate the clinical outcome of a radiotherapy treatment and to approve the treatment plan of the patient if the dose constraints are respected. On the other hand, the γ-maps tool can be used as quality assurance (QA) process to check the predicted TCP and NTCP from radiobiological models. Keywords: Tumor control probability (TCP); normal tissue complication probability (NTCP); radiotherapy; gamma Submitted Apr 6, 26. Accepted for publication Apr 25, 26. doi:.237/tlcr View this article at: Introduction Modern radiotherapy treatment planning systems (TPS) and irradiation techniques provide an increasing number of competing treatment plans, showing more accurate dose distributions in the patient. The clinical data sets for radiotherapy outcomes are also relevant and can be used to compare the radiobiological results from different plans. In recent years, the commercially available TPS have a mathematical algorithms and dose response models to objectively compare the treatment plans and make a clinical
2 266 Chaikh and Balosso. Assessing the shift of radiobiological in radiotherapy using 2D gamma Patient CT-acquisition 2D gamma Plan Dose calculation with MB Plan 2 Dose calculation with AAA γrates 2D γ-maps TCP/NTCP 2D dose maps 2D dose maps TCP/NTCP Correlation with ΔTCP/NTCP Correlation with 2D dose Figure Flowchart from CT acquisition to statistical analysis. CT, computed tomography; TCP, tumor control probability; NTCP, normal tissue complication probability; MB, Modified Batho; AAA, anisotropic analytical algorithm. the same beam s arrangement making a change of dose distribution due to lung density correction. The dose in plan was calculated using Modified Batho s integrated with pencil beam convolution (MB-PBC) algorithm and the dose in plan 2 was recalculated with anisotropic analytical algorithm (AAA) (9-2). Figure shows a flowchart from the CT acquisition to the statistical analysis to evaluate the correlation between radiobiological metrics and γ results (Figure ). We declare that the article does not require a Statement of Ethics, since all the clinical material was anonymized CT scans images used for dosimetric repeated assay s at a remote time from the real treatment of the patients as mentioned in clinical cases and treatment planning. Absolutely no information concerning the patients, themself, were used, so no consent were necessary. The study has been carried out in the University Hospital of Grenoble, France. decision (-8). They were able to compute radiobiological metrics including tumor control probability (TCP) and normal tissue complication probability (NTCP). The decision to select a particular plan for treatment is generally made by a radiation oncologist or a medical physicist based on better values of TCP and lower toxicity predicted by NTCP models. However, when moving from former algorithm to the new generations without any clinical data, it would be difficult to select the better estimated radiobiological parameters models. The purpose of this paper is to assess the shift of TCP/NTCP radiobiological outcomes in radiotherapy plans using 2D gamma (γ) topographic. Then, to test the correlation between γ passing rates (γ-rates) or (γ-mean) with ΔTCP/ΔNTCP in order to select the more clinically relevant γ to compare radiotherapy plans. Methods The clinical cases and treatment planning This study is based on nine patients with lung cancer. The computed tomography (CT-scans) images of each patient were loaded into Eclipse TPS (Varian Medical Systems, Palo Alto, CA, USA). Clinicians delineated the anatomic borders of target volumes (TV) and organs at risks (OAR) including healthy lung and spinal cord, etc. Prescription dose ranged from 5 to 66 Gy in 2 Gy per fraction. Two treatment plans were generated for each patient using The 2D gamma passing rates The γ index combines two criteria including the dose difference (ΔDose) in percentage and the distance-toagreement (DTA) in millimeters (mm). An ellipse is used to determine the acceptable region, and γ represents fulfillment of the criteria (3-5). Our goal, firstly was to determine the volume ratio receiving the same irradiation, in terms of γ, including the TV and OAR. Secondly, to test if 2D γ-maps illustrate the change of TCP/NTCP. The DICOM images for each patient were exported from TPS to RIT-3 (Dosimetry System Version 5.2, Radiological Imaging Technology, Inc., CO) including the dose distributions. The dimensions were 2 2 cm² with a resolution of.39 mm. The results were displayed using 2D γ topography (γ-maps). The γ-maps show the pixels with γ values greater than unity that were outside of tolerance range. To obtain γ values and generate γ-maps. The pixels with γ present the pixels from the tested plan and reference plan having the same dose distribution. The pixels with γ> show either an under- or overestimated dosage associated with plan 2 compared to plan. In order to discriminate between an over- and an under-estimated dose, a color code was attributed to the ΔDose. The difference in percentage was calculated as: ΔDose (%) = (Dplan2 - Dplan) /Dplan2 [] The gamma criteria 2%/2 and 3%/3 mm were used. The
3 Translational Lung Cancer Research, Vol 5, No 3 June percentage of pixels (PP) having a dose out the tolerance (±2% or ±3%), were separated into fractions: + - PP = (PD ) + (PD ) [2] where PD + is the pixels exceeding dose tolerance (ΔDose >+2%) presenting the pixels having more dose, Dplan2 > Dplan. PD is the pixels exceeding dose tolerance (ΔDose < 2%) presenting the pixels having lower dose, Dplan2 < Dplan. Using the γ criteria 2%/3 or 3%/3 mm, we considered that the reference and tested plans were similar, if 95% of pixels had γ. Radiobiological model and outcomes assessment TCP: the equivalent uniform dose (EUD) model proposed by Niemierko 997 was used to estimate TCP (6-8): TCP = 4γ5 5 + TCD [3] EUD EUD was calculated as: /a a EUD = v D i i [4] i where vi is the fractional organ volume receiving a dose Di and a is a tissue specific parameter that describes the volume effect and γ 5 describes the slope of the doseresponse curve. TCD 5 is the dose to control 5% of the tumors. The following input parameters, for the TCP model for lung tumors, were used: TCD 5 =5.24, γ 5 =.83 and a= (9). NTCP: the LKB model was used for estimating NTCP on lung pneumonitis (2-23): NTCP = 2π t - e 2 x dx - 2 (EUD - TD5) t= [6] m.td5 The parameter m represents the slope of the sigmoid dose response curve and TD5 is the dose for a complication rate of 5%. EUD is the equivalent uniform dose and is calculated as: /n n i Deff = ( vieqd2, ) [7] i where vi is the partial volume, n is the volume effects parameter. EQD2 is the equivalent dose given in 2 Gy fractions. In the present study the radiobiological parameters [5] for lung pneumonitis from Emma were used for PBC and AAA (24). For PBC, the parameters were taken as: n=.99, m=.37, TD 5 =3.78 Gy. For AAA, the parameters were: n=.99, m=.374, and TD 5 =29.9 Gy. In addition, we used α/β=3. Gy for normal lung tissue. The statistical analysis Bootstrap simulation method with, random samplings was used to calculate the 95% confidence interval (95% CI) for TCP and NTCP. The statistical significance difference for TCP/NTCP from plans and plans 2 was assessed using the Wilcoxon signed-rank test. The significant difference is considered when P<.5 (25). In addition, the agreement between γ-rates with ΔTCP or ΔNTCP was statistically assessed using the correlation coefficient (ρ) from Spearman s rank test. Results The 2D dose distribution Figure 2 shows a 2D dose maps plotted in the axial plane using CT-scan corresponding to treatment for one patient. It can be seen in Figure 2 that the 95% isodose does not cover properly the target in plan 2, but they were extended more in the lateral direction and encompasses more normal lung tissue (Figure 2). The gamma passing rates Figure 3 shows the results of γ-rates indicating the total pixels with γ>, under and over dosed pixels for 2%/2 and 3%/3. It can be seen on Figure 3 that both methods, PBC-MB and AAA, yield much difference using 2%/2 or 3%/3 mm (Figure 3). Figure 4 shows a sample of a 2D γ-maps in the axial views illustrating the γ values and dose differences. The 2D γ-maps were calculated using DICOM images from plan and plan 2 including tumor and organs at risks. The red and blue coloring indicate that γ> and identifying PD + or PD (Figure 4). Radiobiological metrics Figure 5 shows the results of bootstrap distributions based on, replications for TCP and NTCP with 95% CI from PBC-MB or AAA. It can be seen in Figure 5 that MB-PBC in plan predicted more TCP with lower NTCP, P=.3 (Figure 5).
4 268 Chaikh and Balosso. Assessing the shift of radiobiological in radiotherapy using 2D gamma Figure 2 Dose maps in 2D plotted in the axial plane using CT-scan corresponding to treatment for one patient. Left images are MB prediction and right images the AAA one showing obvious shift for dose distribution. CT, computed tomography; MB, Modified Batho; AAA, anisotropic analytical algorithm. Total pixels with γ> Figure 3 Results of 2D γ passing rates indicating the total pixels with γ>, under dosed pixels (PD ) and overdosed pixels (PD + ) using 2%/2 and 3%/3 mm criteria. Correlation and sensitivity analysis We observed a weak correlation between γ-rates and ΔTCP or ΔNTCP for 2%/2 or 3%/3 mm. A similar weak correlation between γ-mean and radiobiological metrics was observed, with ρ<.3. Discussion PP (γ>) 2%/2 mm 3%/3 mm Numerous studies have evaluated the correlation between γ-rates and dose volume histogram (DVH) metrics PD + PD per organ (26-28). They reported a poor correlation between γ-rates and DVH data. Recent studies applied the radiobiological metrics on quality assurance (QA) process with intensity modulated radiation therapy techniques (29-3). They reported the potential useful of biological metrics in-patient specific QA for evaluating the clinical outcome of a radiotherapy treatment. This paper highlights the discrepancies in estimating TCP/NTCP based on EUD and LKB models, respectively, for the same patient and prescribed dose using MB-PBC versus AAA. In our study firstly, we observed an overestimation of TCP by MB-PBC than AAA. On the other hand, a remarkable and significant discrepancy in estimating NTCP was observed confirming the results of several other studies (32-34). Secondly, γ-maps confirmed the observed results from CT imaging showing dose distribution. For example, it can be seen in Figure 3 that the 95% isodose does not cover the target at all in plan 2, but they were more extended in lateral direction in normal tissues. This will affect the target coverage and TCP values as well as NTCP. The observed results with 2D gamma maps confirm the results from 2D dose maps with CT-scans and alter the change of TCP/NTCP. Furthermore, the tolerance 95% of pixels with γ is not respected, predicting a significant difference between plan and plan 2. The changes of dose distribution in the target and OAR should be taken into
5 Translational Lung Cancer Research, Vol 5, No 3 June ΔDose % γ-value Figure 4 2D-γ maps plotted on the axial views for comparing plan with plan 2. The red and blue coloring indicate that γ> (right panel) and are identifying as over/under estimated dose for pixels (left panel). Probability % P=.3 P=.3 TCP with more NTCP than the plans calculated by MB- PBC. The radiobiological results were predicted using 2D gamma maps indicating a significate fraction of normal tissue or target would be respectively over/under dosed. However, a weak correlation was observed between the ΔTCP/ΔNTCP and the gamma passing rates with 2%/2 or 3%/3 mm criteria. NTCP-MB NTCP-AAA TCP-MB Radiobilogical metrics TCP-AAA Acknowledgements Figure 5 Results of TCP and NTCP radiobiological metrics from MB-PBC and AAA with 95% CI using bootstrap simulation with, replications. TCP, tumor control probability; NTCP, normal tissue complication probability; MB-PBC, Modified Batho method integrated with pencil beam convolution; AAA, anisotropic analytical algorithm. consideration to meet the dose constraints when using plan 2 to treat the patient. However, the limit of this study is that we used the physical dose, DVH, to estimate the TCP/NTCP. In addition, uncertainty to estimate the radiological outcomes can occur due to the limit of model or radiobiological parameters (n, m and TD5). In this study, we used the more relevant parameters published for each algorithm, PBC or AAA, to minimize the over/ underestimated values and to obtain the more accurate TCP/NTCP. Conclusions In this study, the plans recalculated with AAA yielded lower This work has been partially funded by France HADRON (an academic non profit organization) in the frame of the ProtonShare project. Footnotes Conflicts of Interest: The authors have no conflicts of interest to declare. References. Allen Li X, Alber M, Deasy JO, et al. The use and QA of biologically related models for treatment planning: short report of the TG-66 of the therapy physics committee of the AAPM. Med Phys 22;39: Zaider M, Minerbo GN. Tumour control probability: A formulation applicable to any temporal protocol of dose delivery. Phys Med Biol 2;45: Bentzen SM, Tucker SL. Quantifying the position and steepness of radiation dose response curves. Int J Radiat Biol 997;7: Tucker SL, Taylor JM. Improved models of tumour cure.
6 27 Chaikh and Balosso. Assessing the shift of radiobiological in radiotherapy using 2D gamma Int J Radiat Biol 996;7: Martel MK, Ten Haken RK, Hazuka MB, et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 999;24: Fenwick JD, Nahum AE, Malik ZI, et al. Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement. Clin Oncol (R Coll Radiol) 29;2: Nahum AE, Sanchez-Nieto B. Tumour control probability modelling: basic principles and applications in treatment planning. Phys Med 2;7: Webb S, Nahum AE. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol 993;38: Batho HF. Lung corrections in cobalt 6 beam therapy. J Can Assoc Radiol 964;5: El-Khatib E, Battista JJ. Improved lung dose calculation using tissue-maximum ratios in the Batho correction. Med Phys 984;: Sievinen J, Ulmer W, Kaissl W. AAA Photon Dose Calculation Model in Eclipse. Palo Alto (CA): Varian Medical Systems, Rana S. Clinical dosimetric impact of Acuros XB and analytical anisotropic algorithm (AAA) on real lung cancer treatment plans: review. Int J Cancer Ther Oncol 24;2: Low DA, Harms WB, Mutic S, et al. A technique for the quantitative evaluation of dose distributions. Med Phys 998;25: Spezi E, Lewis DG. Gamma histograms for radiotherapy plan evaluation. Radiother Oncol 26;79: Chaikh A, Giraud JY, Balosso J. A 3D quantitative evaluation for assessing the changes of treatment planning system and irradiation techniques in radiotherapy. Int J Cancer Ther Oncol 24;2: Niemierko A. A unified model of tissue response to radiation. In: Proceedings of the 4th AAPM annual meeting; 999. Nashville, Tennessee: Med Phys 999:. 7. Niemierko A. Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med Phys 997;24: Niemierko A. A generalized concept of equivalent uniform dose (EUD). Med Phys 999;26:. 9. Okunieff P, Morgan D, Niemierko A, et al. Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys 995;32: Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 985;8:S Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys 989;6: Kutcher GJ, Burman C, Brewster L, et al. Histogram reduction method for Calculation complication probabilities for three dimensional treatment evaluation. Int J Radiat Oncol Biol Phys 99;2: Burman C, Kutcher GJ, Emami B, et al. Fitting of normal tissue tolerance data to an analytic fuction. Int J Radiat Oncol Biol Phys 99;2: Hedin E, Bäck A. Influence of different dose calculation algorithms on the estimate of NTCP for lung complications. J Appl Clin Med Phys 23;4: Chaikh A, Giraud JY, Perrin E, et al. The choice of statistical methods for comparisons of dosimetric data in radiotherapy. Radiat Oncol 24;9: Nelms BE, Zhen H, Tomé WA. Per-beam, planar IMRT QA passing rates do not predict clinically relevant patient dose errors. Med Phys 2;38: Zhen H, Nelms BE, Tome WA. Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA. Med Phys 2;38: Stasi M, Bresciani S, Miranti A, et al. Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram. Med Phys 22;39: Zhen H, Nelms BE, Tomé WA. On the use of biomathematical models in patient-specific IMRT dose QA. Med Phys 23;4: Clemente-Gutiérrez F, Pérez-Vara C, Clavo-Herranz MH, et al. Assessment of radiobiological metrics applied to patient-specific QA process of VMAT prostate treatments. J Appl Clin Med Phys 26;7: Sumida I, Yamaguchi H, Kizaki H, et al. Novel Radiobiological Gamma Index for Evaluation of 3-Dimensional Predicted Dose Distribution. Int J Radiat Oncol Biol Phys 25;92: Chetty IJ, Devpura S, Liu D, et al. Correlation of dose computed using different algorithms with local control following stereotactic ablative radiotherapy (SABR)-based treatment of non-small-cell lung cancer. Radiother Oncol 23;9: Liu MB, Eclov NC, Trakul N, et al. Clinical impact of dose overestimation by effective path length calculation
7 Translational Lung Cancer Research, Vol 5, No 3 June in stereotactic ablative radiation therapy of lung tumors. Pract Radiat Oncol 23;3: Chandrasekaran M, Panettieri V, Baker C, et al. The clinical impact of differences in photon dose algorithms: 3DCRT and SBRT of lung tumors. Radiother Oncol 2;99:S Cite this article as: Chaikh A, Balosso J. Assessing the shift of radiobiological metrics in lung radiotherapy plans using 2D gamma index.. doi:.237/tlcr.26.6.
Abdulhamid Chaikh 1,2, Jacques Balosso 1,2. Introduction
Original Article Statistical control process to compare and rank treatment plans in radiation oncology: impact of heterogeneity correction on treatment planning in lung cancer Abdulhamid Chaikh 1,2, Jacques
More informationThe bootstrap method to improve statistical analysis of dosimetric data for radiotherapy outcomes
The bootstrap method to improve statistical analysis of dosimetric data for radiotherapy outcomes Abdulhamid Chaikh1,2, Jean-Pierre Bresciani3,4, Jacques Balosso2,4 1Department of Radiation Oncology and
More informationIn-silico study to compare proton versus photon radiotherapy: a modelization based decision protocol ProtonShare Project
In-silico study to compare proton versus photon radiotherapy: a modelization based decision protocol ProtonShare Project Abdulhamid Chaikh, Jacques Balosso Department of Radiation Oncology and Medical
More informationReceived October 03, 2016; Revised December 15, 2016; Accepted December 20, 2016; Published Online, December 28, 2016
International Journal of Cancer Therapy and Oncology What should we know about photon dose calculation algorithms used for radiotherapy? Their impact on dose distribution and medical decisions based on
More informationRadiobiological Impact of Planning Techniques for Prostate Cancer in Terms of Tumor Control Probability and Normal Tissue Complication Probability
Original Article Radiobiological Impact of Planning Techniques for Prostate Cancer in Terms of Tumor Control Probability and Normal Tissue Complication Probability Rana S, Cheng CY Department of Medical
More informationOptimising Radiotherapy Using NTCP Models: 17 Years in Ann Arbor
Individualizing Optimizing Optimising Radiotherapy Using NTCP Models: 17 Years in Ann Arbor Randall K. Ten Haken, Ph.D. University of Michigan Department of Radiation Oncology Ann Arbor, MI Introduction
More informationFeasibility of the partial-single arc technique in RapidArc planning for prostate cancer treatment
Chinese Journal of Cancer Original Article Feasibility of the partial-single arc technique in RapidArc planning for prostate cancer treatment Suresh Rana 1 and ChihYao Cheng 2 Abstract The volumetric modulated
More informationCommission, Ganakbari, Savar, Dhaka, Bangladesh
International Letters of Chemistry, Physics and Astronomy Submitted: 2016-05-17 ISSN: 2299-3843, Vol. 68, pp 54-60 Revised: 2016-07-08 doi:10.18052/www.scipress.com/ilcpa.68.54 Accepted: 2016-07-12 2016
More informationKnowledge-Based IMRT Treatment Planning for Prostate Cancer: Experience with 101. Cases from Duke Clinic. Deon Martina Dick
Knowledge-Based IMRT Treatment Planning for Prostate Cancer: Experience with 101 Cases from Duke Clinic by Deon Martina Dick Department of Medical Physics Duke University Date: Approved: Joseph Lo, Chair
More informationDosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer
Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer Tan Chek Wee 15 06 2016 National University Cancer Institute, Singapore Clinical Care Education Research
More informationRanking radiotherapy treatment plans: physical or biological objectives?
Ranking radiotherapy treatment plans: physical or biological objectives? Martin Ebert Department of Radiation Oncology, Sir Charles Gairdner Hospital, Western Australia, Australia Background. The ranking
More informationThe MapCHECK Measurement Uncertainty function and its effect on planar dose pass rates
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 17, NUMBER 2, 2016 The MapCHECK Measurement Uncertainty function and its effect on planar dose pass rates Daniel W. Bailey, 1,2 a Jason D. Spaans, 2
More informationBiological/Clinical Outcome Models in RT Planning
Biological/Clinical Outcome Models in RT Planning Randy Ten Haken Ken Jee University of Michigan Why consider use of models? Are there problems that use of outcomes models could help resolve? Would their
More informationDosimetric Uncertainties and Normal Tissue Tolerance. Ellen D Yorke Memorial Sloan Kettering Cancer Center New York City
Dosimetric Uncertainties and Normal Tissue Tolerance Ellen D Yorke Memorial Sloan Kettering Cancer Center New York City Traditional accuracy/precision goal is to deliver external beam radiation therapy
More informationLeila E. A. Nichol Royal Surrey County Hospital
2 nd UK and Ireland Dosimetry Check User Meeting Symposium Clatterbridge Cancer Centre, 24 th October 2012 Leila E. A. Nichol Royal Surrey County Hospital Leila.Nichol@nhs.net *My experience with Dosimetry
More informationQuality Assurance of TPS: comparison of dose calculation for stereotactic patients in Eclipse and iplan RT Dose
Petrovic B Comparison of dose calculation algorithms for stereotaxy Quality Assurance of TPS: comparison of dose calculation for stereotactic patients in and RT Dose Borislava Petrovic 1, Aleksandra Grządziel
More informationA new homogeneity index based on statistical analysis of the dose volume histogram
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 8, NUMBER 2, SPRING 2007 A new homogeneity index based on statistical analysis of the dose volume histogram Myonggeun Yoon, Sung Yong Park, a Dongho
More informationEvaluation of Dosimetry Check software for IMRT patient-specific quality assurance
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 16, NUMBER 3, 2015 Evaluation of Dosimetry Check software for IMRT patient-specific quality assurance Ganesh Narayanasamy, Travis Zalman, Chul S. Ha,
More informationKaneko et al. Radiation Oncology (2019) 14:36
Kaneko et al. Radiation Oncology (2019) 14:36 https://doi.org/10.1186/s13014-019-1233-0 RESEARCH Comparison of gamma index based on dosimetric error and clinically relevant dose volume index based on threedimensional
More informationBiologically Based Treatment Planning X. Allen Li
Biologically Based Treatment Planning X. Allen Li AAPM Spring Clinical Meeting, March 20, 2012 Limitations of dose-volume based treatment planning DV metrics are merely surrogate measures of radiation
More informationProstate volumetric-modulated arc therapy: dosimetry and radiobiological model variation between the single-arc and double-arc technique
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 14, NUMBER 3, 2013 Prostate volumetric-modulated arc therapy: dosimetry and radiobiological model variation between the single-arc and double-arc technique
More informationRectal dose and toxicity dosimetric evaluation for various beam arrangements using pencil beam scanning protons with and without rectal spacers
Rectal dose and toxicity dosimetric evaluation for various beam arrangements using pencil beam scanning protons with and without rectal spacers 2015 MAC-AAPM Annual Meeting, Baltimore, MD Heeteak Chung,
More informationX. Allen Li BGRT. Biologically Based Treatment Planning. Biologically based treatment planning
Biologically Based Treatment Planning X. Allen Li AAPM Spring Clinical Meeting, March 20, 2012 Limitations of dose-volume based treatment planning DV metrics are merely surrogate measures of radiation
More informationDefining Target Volumes and Organs at Risk: a common language
Defining Target Volumes and Organs at Risk: a common language Eduardo Rosenblatt Section Head Applied Radiation Biology and Radiotherapy (ARBR) Section Division of Human Health IAEA Objective: To introduce
More informationEvaluation of Dynamic Delivery Quality Assurance Process for Internal Target Volume Based RapidArc
Original Article PMP Progress in Medical Physics 28(4), December 217 https://doi.org/1.14316/pmp.217.28.4.181 pissn 258-4445, eissn 258-4453 Evaluation of Dynamic Delivery Quality Assurance Process for
More informationWill CyberKnife M6 Multileaf collimator offer advantages over IRIS collimator in prostate SBRT?
Will CyberKnife M6 Multileaf collimator offer advantages over collimator in prostate SBRT? Vindu Kathriarachchi Professional Science Master in Medical Physics Department of Physics, Florida Atlantic University,
More informationCredentialing for Clinical Trials -IGRT. Evidence Based Radiation Oncology. Levels of Clinical Evidence. Why Credentialing?
Acknowledgements Credentialing for Clinical Trials -IGRT Invitation from Organizers RTOG Headquarter QA Team ATC Collaborators Evidence Based Radiation Oncology Clinical Trials From Collaborative Groups
More informationAssessing Heterogeneity Correction Algorithms Using the Radiological Physics Center Anthropomorphic Thorax Phantom
Assessing Heterogeneity Correction Algorithms Using the Radiological Physics Center Anthropomorphic Thorax Phantom David Followill, Ph.D. Associate Director Radiological Physics Center RPC History Lesson
More informationComparing conformal, arc radiotherapy and helical tomotherapy in craniospinal irradiation planning
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 15, NUMBER 5, 2014 Comparing conformal, arc radiotherapy and helical tomotherapy in craniospinal irradiation planning Pamela A. Myers, 1 Panayiotis Mavroidis,
More informationActivity report from JCOG physics group
2013.5.9 Global Harmonization Group meeting ICCR2013 @ Melbourne Activity report from JCOG physics group 1 Hokkaido University, Graduate School of Medicine, 2 National Cancer Center, Center for Cancer
More informationRadiobiological Impact of Acuros XB Dose Calculation Algorithm on Low-Risk Prostate Cancer Treatment Plans Created by RapidArc Technique.
Radiobiological Impact of Acuros XB Dose Calculation Algorithm on Low-Risk Prostate Cancer Treatment Plans Created by RapidArc Technique. 1,2 Suresh Rana, M.S., 2 Kevin Rogers, M.S. 1 Department of Medical
More information3-Dimensional conformal radiotherapy versus intensity modulated radiotherapy for localized prostate cancer: Dosimetric and radiobiologic analysis
Iran. J. Radiat. Res., 2007; 5 (1): 1-8 3-Dimensional conformal radiotherapy versus intensity modulated radiotherapy for localized prostate cancer: Dosimetric and radiobiologic analysis A.K. Bhardwaj 1*,T.S.
More informationRadiation Damage Comparison between Intensity Modulated Radiotherapy (IMRT) and Field-in-field (FIF) Technique In Breast Cancer Treatments
Radiation Damage Comparison between Intensity Modulated Radiotherapy () and Field-in-field (FIF) Technique In Breast Cancer Treatments Huisi Ai 1 and Hualin Zhang 2 1. Department of Radiation Oncology,
More information4.1.1 Dose distributions LKB effective volume or mean liver dose? The critical volume model TUMOUR CONTROL...
1 CONTENTS 1 INTRODUCTION... 3 1.1 STEREOTACTIC BODY RADIATION THERAPY (SBRT)... 3 1.1.1 The development of SBRT... 3 1.1.2 The technique of SBRT... 4 1.1.3 Hypofractionation and inhomogeneous dose distribution...
More informationGeometric dose prediction model for hemithoracic intensity-modulated radiation therapy in mesothelioma patients with two intact lungs
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 17, NUMBER 3, 2016 Geometric dose prediction model for hemithoracic intensity-modulated radiation therapy in mesothelioma patients with two intact lungs
More informationDoes the IMRT technique allow improvement of treatment plans (e.g. lung sparing) for lung cancer patients with small lung volume: a planning study
Does the IMRT technique allow improvement of treatment plans (e.g. lung sparing) for lung cancer patients with small lung volume: a planning study Received: 22.04.2008 Accepted: 4.07.2008 Subject: original
More informationSilvia Pella, PhD, DABR Brian Doozan, MS South Florida Radiation Oncology Florida Atlantic University Advanced Radiation Physics Boca Raton, Florida
American Association of Medical Dosimetrists 2015 Silvia Pella, PhD, DABR Brian Doozan, MS South Florida Radiation Oncology Florida Atlantic University Advanced Radiation Physics Boca Raton, Florida Most
More informationImpact of Contouring Variability on Dose- Volume Metrics used in Treatment Plan Optimization of Prostate IMRT
Open Access Original Article DOI: 10.7759/cureus.144 Impact of Contouring Variability on Dose- Volume Metrics used in Treatment Plan Optimization of Prostate IMRT Arvand Barghi, Carol Johnson 2, Andrew
More informationTransition to Heterogeneity Corrections. Why have accurate dose algorithms?
Transition to Heterogeneity Corrections Eric E. Klein, M.S., Washington University, St. Louis, MO Craig Stevens, M.D., Ph.D., MD Anderson Cancer Center, Houston, TX Nikos Papinikolou, Ph.D., University
More informationDetermination and Use of Radiobiological Response Parameters in Radiation Therapy Optimization. Panayiotis Mavroidis
Determination and Use of Radiobiological Response Parameters in Radiation Therapy Optimization Panayiotis Mavroidis Division of Medical Radiation Physics Department of Oncology-Pathology Karolinska Institutet
More informationA comparative dosimetric analysis of the effect of heterogeneity corrections used in three treatment planning algorithms
The University of Toledo The University of Toledo Digital Repository Theses and Dissertations 2010 A comparative dosimetric analysis of the effect of heterogeneity corrections used in three treatment planning
More informationDepartment of Radiation Oncology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea
J. Korean Soc Ther Radiol Oncol : Vol. 15, No. 3, September, 1997, Department of Radiation Oncology, AsanMedical Center, College of Medicine, University of Ulsan, Seoul, Korea Purpose:In radiation therapy,
More informationIMRT - the physician s eye-view. Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia
IMRT - the physician s eye-view Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia The goals of cancer therapy Local control Survival Functional status Quality of life Causes
More informationTHE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS
THE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS ICTP SCHOOL ON MEDICAL PHYSICS FOR RADIATION THERAPY DOSIMETRY AND TREATMENT PLANNING FOR BASIC AND ADVANCED APPLICATIONS March
More informationDose escalation in permanent brachytherapy for prostate cancer: dosimetric and biological considerations*
INSTITUTE OF PHYSICS PUBLISHING Phys. Med. Biol. 48 (2003) 2753 2765 PHYSICS IN MEDICINE AND BIOLOGY PII: S0031-9155(03)62377-8 Dose escalation in permanent brachytherapy for prostate cancer: dosimetric
More informationQuality assurance and credentialing requirements for sites using inverse planned IMRT Techniques
TROG 08.03 RAVES Quality assurance and credentialing requirements for sites using inverse planned IMRT Techniques Introduction Commissioning and quality assurance of planning systems and treatment delivery
More informationIMRT QA: Point Dose Measurements or 2D Array?
QA for IMRT IMRT QA: Point Dose Measurements or D Array? General Linac QA for IMRT MLC checks Dose linearity at low MU Patient-specific measurements Performed using various methods Purpose is to verify
More informationSBRT fundamentals. Outline 8/2/2012. Stereotactic Body Radiation Therapy Quality Assurance Educational Session
Stereotactic Body Radiation Therapy Quality Assurance Educational Session J Perks PhD, UC Davis Medical Center, Sacramento CA SBRT fundamentals Extra-cranial treatments Single or small number (2-5) of
More informationMargins in SBRT. Mischa Hoogeman
Margins in SBRT Mischa Hoogeman MARGIN CONCEPTS Why do we use margins? Target / tumor To a-priori compensate for (unknown) deviations between the intended target position and the real target position during
More informationAn anthropomorphic head phantom with a BANG polymer gel insert for dosimetric evaluation of IMRT treatment delivery
An anthropomorphic head phantom with a BANG polymer gel insert for dosimetric evaluation of IMRT treatment delivery G. Ibbott a, M. Beach a, M. Maryanski b a M.D. Anderson Cancer Center, Houston, Texas,
More informationRadiation Planning Index for dose distribution evaluation in stereotactic radiotherapy
Radiation Planning Index for dose distribution evaluation in stereotactic radiotherapy Krzysztof ŚLOSAREK, Aleksandra GRZĄDZIEL, Marta SZLAG, Joanna BYSTRZYCKA Received: 8.4.28 Accepted: 9.8.28 Subject:
More informationChapters from Clinical Oncology
Chapters from Clinical Oncology Lecture notes University of Szeged Faculty of Medicine Department of Oncotherapy 2012. 1 RADIOTHERAPY Technical aspects Dr. Elemér Szil Introduction There are three possibilities
More informationOriginal Article. Teyyiba Kanwal, Muhammad Khalid, Syed Ijaz Hussain Shah, Khawar Nadeem
Original Article Treatment Planning Evaluation of Sliding Window and Multiple Static Segments Technique in Intensity Modulated Radiotherapy for Different Beam Directions Teyyiba Kanwal, Muhammad Khalid,
More informationDosimetric Analysis Report
RT-safe 48, Artotinis str 116 33, Athens Greece RT-safe +30 2107563691 info@rt-safe.com Dosimetric Analysis Report SAMPLE, for demonstration purposes only Date of report: ------ Irradiation system: ------
More informationAccuracy Requirements and Uncertainty Considerations in Radiation Therapy
Departments of Oncology and Medical Biophysics Accuracy Requirements and Uncertainty Considerations in Radiation Therapy Introduction and Overview 6 August 2013 Jacob (Jake) Van Dyk Conformality 18 16
More informationRole of Belly Board Device in the Age of Intensity Modulated Radiotherapy for Pelvic Irradiation
Role of Belly Board Device in the Age of Intensity Modulated Radiotherapy for Pelvic Irradiation 2017 AAMD 42 nd Annual Meeting Neil C. Estabrook, MD 6 / 14 / 2017 7/5/2017 1 Conflicts of Interest None
More informationNovel techniques for normal tissue toxicity modelling. Laura Cella Institute of Biostructures and Bioimaging National Research Council of Italy
Novel techniques for normal tissue toxicity modelling Laura Cella Institute of Biostructures and Bioimaging National Research Council of Italy Disclosure: I have no conflict of interest An honorarium is
More informationEvaluation of Normal Tissue Complication Probability and Risk of Second Primary Cancer in Prostate Radiotherapy
Evaluation of Normal Tissue Complication Probability and Risk of Second Primary Cancer in Prostate Radiotherapy Rungdham Takam Thesis submitted for the degree of Doctor of Philosophy in The School of Chemistry
More informationCRT combined with a sequential VMAT boost in the treatment of upper thoracic esophageal cancer
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 14, NUMBER 5, 2013 CRT combined with a sequential VMAT boost in the treatment of upper thoracic esophageal cancer Xiance Jin, Jinling Yi, Yongqiang Zhou,
More informationProject IX: Big Data Meets Medical Physics Dosimetry
Project IX: Big Data Meets Medical Physics Dosimetry Foundations and Recent Advances Fumbeya Marungo, Hilary Paisley, John Rhee Dr. Todd McNutt Dr. Scott Robertson Topic Goal improve radiotherapy risk
More informationGamma analysis dependence on specified low-dose thresholds for VMAT QA
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 16, NUMBER 6, 2015 Gamma analysis dependence on specified low-dose thresholds for VMAT QA Ji-Hye Song, 1 Min-Joo Kim, 1 So-Hyun Park, 1,2 Seu-Ran Lee,
More informationA VMAT PLANNING SOLUTION FOR NECK CANCER PATIENTS USING THE PINNACLE 3 PLANNING SYSTEM *
Romanian Reports in Physics, Vol. 66, No. 2, P. 401 410, 2014 A VMAT PLANNING SOLUTION FOR NECK CANCER PATIENTS USING THE PINNACLE 3 PLANNING SYSTEM * M. D. SUDITU 1,2, D. ADAM 1,2, R. POPA 1,2, V. CIOCALTEI
More informationREVISITING ICRU VOLUME DEFINITIONS. Eduardo Rosenblatt Vienna, Austria
REVISITING ICRU VOLUME DEFINITIONS Eduardo Rosenblatt Vienna, Austria Objective: To introduce target volumes and organ at risk concepts as defined by ICRU. 3D-CRT is the standard There was a need for a
More informationHeterogeneity Corrections in Clinical Trials
Heterogeneity Corrections in Clinical Trials Niko Papanikolaou Departments of Radiology and Radiation Oncology U of TX Health Science Center, San Antonio, TX Eric Klein Department of Radiation Oncology
More informationClinical Impact of Couch Top and Rails on IMRT and Arc Therapy
Texas Medical Center Library DigitalCommons@TMC UT GSBS Dissertations and Theses (Open Access) Graduate School of Biomedical Sciences 8-2011 Clinical Impact of Couch Top and Rails on IMRT and Arc Therapy
More informationFollow this and additional works at: Part of the Medicine and Health Sciences Commons
Texas Medical Center Library DigitalCommons@TMC UT GSBS Dissertations and Theses (Open Access) Graduate School of Biomedical Sciences 8-2012 EVALUATION OF THE EFFECTIVENESS OF ANISOTROPIC ANALYTICAL ALGORITHM
More informationTreatment Planning Evaluation of Volumetric Modulated Arc Therapy (VMAT) for Craniospinal Irradiation (CSI)
Treatment Planning Evaluation of Volumetric Modulated Arc Therapy (VMAT) for Craniospinal Irradiation (CSI) Tagreed AL-ALAWI Medical Physicist King Abdullah Medical City- Jeddah Aim 1. Simplify and standardize
More informationAutomated Plan Quality Check with Scripting. Rajesh Gutti, Ph.D. Clinical Medical Physicist
Automated Plan Quality Check with Scripting Rajesh Gutti, Ph.D. Clinical Medical Physicist Veera.Gutti@BSWHealth.org Outline Introduction - BSW Automation in Treatment planning Eclipse Scripting API Script
More information8/2/2018. Acknowlegements: TCP SPINE. Disclosures
A Presentation for the AAPM Annual meeting, Aug 2, 2018 Nashville, TN Stereotactic Radiosurgery for Spinal Metastases: Tumor Control Probability Analyses and Recommended Reporting Standards for Future
More informationCURRICULUM OUTLINE FOR TRANSITIONING FROM 2-D RT TO 3-D CRT AND IMRT
CURRICULUM OUTLINE FOR TRANSITIONING FROM 2-D RT TO 3-D CRT AND IMRT Purpose The purpose of this curriculum outline is to provide a framework for multidisciplinary training for radiation oncologists, medical
More informationCan we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer?
Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer? Dimos Baltas Dept. of Medical Physics & Engineering, Strahlenklinik, Klinikum Offenbach GmbH 63069 Offenbach, Germany
More informationDosimetric benefits of IMRT and VMAT in the treatment of middle thoracic esophageal cancer: is the conformal radiotherapy still an alternative option?
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 15, NUMBER 3, 2014 Dosimetric benefits of IMRT and VMAT in the treatment of middle thoracic esophageal cancer: is the conformal radiotherapy still an
More informationEvaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer
1 Charles Poole April Case Study April 30, 2012 Evaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer Abstract: Introduction: This study
More informationBaotian Huang 1, Lili Wu 1, Peixian Lin 2 and Chuangzhen Chen 1*
Huang et al. Radiation Oncology (2015) 10:53 DOI 10.1186/s13014-015-0357-0 RESEARCH Open Access Dose calculation of Acuros XB and Anisotropic Analytical Algorithm in lung stereotactic body radiotherapy
More informationA Dosimetric Comparison of Whole-Lung Treatment Techniques. in the Pediatric Population
A Dosimetric Comparison of Whole-Lung Treatment Techniques in the Pediatric Population Corresponding Author: Christina L. Bosarge, B.S., R.T. (R) (T) Indiana University School of Medicine Department of
More informationClinical Implementation of patient-specific dosimetry, comparison with absorbed fraction-based method
Clinical Implementation of patient-specific dosimetry, comparison with absorbed fraction-based method George Sgouros, Ph.D. Russell H. Morgan Dept of Radiology & Radiological Science Johns Hopkins University,
More informationEffect of bladder filling on doses to prostate and organs at risk: a treatment planning study
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 8, NUMBER 1, WINTER 2007 Effect of bladder filling on doses to prostate and organs at risk: a treatment planning study Vitali Moiseenko, 1 Mitchell Liu,
More informationEORTC Member Facility Questionnaire
Page 1 of 9 EORTC Member Facility Questionnaire I. Administrative Data Name of person submitting this questionnaire Email address Function Phone Institution Address City Post code Country EORTC No Enter
More informationA dosimetric comparison between volumetric-modulated arc therapy and dynamic conformal arc therapy in SBRT
JBUON 2019; 24(2): 838-843 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE A dosimetric comparison between volumetric-modulated arc therapy and
More informationThe performance of the progressive resolution optimizer (PRO) for RapidArc planning in targets with low-density media
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 14, NUMBER 6, 2013 The performance of the progressive resolution optimizer (PRO) for RapidArc planning in targets with low-density media Monica W.K.
More informationNormal tissue doses from MV image-guided radiation therapy (IGRT) using orthogonal MV and MV-CBCT
Received: 28 September 2017 Revised: 17 November 2017 Accepted: 28 December 2017 DOI: 10.1002/acm2.12276 RADIATION ONCOLOGY PHYSICS Normal tissue doses from MV image-guided radiation therapy (IGRT) using
More informationThe dependence of optimal fractionation schemes on the spatial dose distribution
The dependence of optimal fractionation schemes on the spatial dose distribution Jan Unkelbach 1, David Craft 1, Ehsan Salari 1, Jagdish Ramakrishnan 1,2, Thomas Bortfeld 1 1 Department of Radiation Oncology,
More informationSpinal Cord Doses in Palliative Lung Radiotherapy Schedules
Journal of the Egyptian Nat. Cancer Inst., Vol. 8, No., June: -, 00 Spinal Cord Doses in Palliative Lung Radiotherapy Schedules HODA AL-BOOZ, FRCR FFRRCSI M.D.* and CAROL PARTON, Ph.D.** The Departments
More informationEvaluation of the radiobiological gamma index with motion interplay in tangential IMRT breast treatment
Journal of Radiation Research, Vol. 57, No. 6, 206, pp. 69 70 doi: 0.093/jrr/rrw073 Advance Access Publication: 6 August 206 Evaluation of the radiobiological gamma index with motion interplay in tangential
More informationIGRT Protocol Design and Informed Margins. Conflict of Interest. Outline 7/7/2017. DJ Vile, PhD. I have no conflict of interest to disclose
IGRT Protocol Design and Informed Margins DJ Vile, PhD Conflict of Interest I have no conflict of interest to disclose Outline Overview and definitions Quantification of motion Influences on margin selection
More informationA dosimetric evaluation of VMAT for the treatment of non-small cell lung cancer
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 14, NUMBER 1, 2013 A dosimetric evaluation of VMAT for the treatment of non-small cell lung cancer Caitlin E. Merrow, a Iris Z. Wang, Matthew B. Podgorsak
More informationICRU Report 91 Was ist neu, was ändert sich?
DEGRO Stereotaxie Meeting 21.10.2017 ICRU Report 91 Was ist neu, was ändert sich? Lotte Wilke, Stephanie Tanadini-Lang, Matthias Guckenberger Klinik für Radio-Onkologie, Universitätsspital Zürich History
More informationFilm-based dose validation of Monte Carlo algorithm for Cyberknife system with a CIRS thorax phantom
Received: 4 August 2017 Revised: 1 January 2018 Accepted: 6 February 2018 DOI: 10.1002/acm2.12314 RADIATION ONCOLOGY PHYSICS Film-based dose validation of Monte Carlo algorithm for Cyberknife system with
More informationCan we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer?
Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer? Dimos Baltas 1,3, Natasa Milickovic 1, Nikolaos Zamboglou 2 1 Dept. of Medical Physics & Engineering, 2 Strahlenklinik,
More informationThe RPC s Evaluation of Advanced Technologies. AAPM Refresher Course July 29, 2008 Geoffrey S. Ibbott, Ph.D. and RPC Staff
The RPC s Evaluation of Advanced Technologies AAPM Refresher Course July 29, 2008 Geoffrey S. Ibbott, Ph.D. and RPC Staff 1 http://rpc.mdanderson.org Supported by: NCI grants CA10953 and CA81647, and an
More information1) Joint Department of Physics, Institute of Cancer Research and Royal Marsden NHS Foundation
1 2 Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise. 3 4 Authors 5 6 Sarah L Gulliford
More informationNew Thinking on Fractionation in Radiotherapy
New Thinking on Fractionation in Radiotherapy Alan E. Nahum Visiting Professor, Physics dept., Liverpool university, UK alan_e_nahum@yahoo.co.uk 1 An honorarium is provided by Accuray for this presentation
More informationIMAT: intensity-modulated arc therapy
: intensity-modulated arc therapy M. Iori S. Maria Nuova Hospital, Medical Physics Department Reggio Emilia, Italy 1 Topics of the talk Rotational IMRT techniques: modalities & dedicated inverse-planning
More informationEvaluation of the Dynamic Arc-Therapy in Comparison to Conformal Radiation Therapy in Radiotherapy Patients
Evaluation of the Dynamic Arc-Therapy in Comparison to Conformal Radiation Therapy in Radiotherapy Patients Aliaa Mahmoud (1,4), Ehab M. Attalla (2,3), M..S. El-Nagdy (4), Gihan Kamel (4) (1) Radiation
More informationRadiobiological modelling applied to Unsealed Source (radio) Therapy
Radiobiological modelling applied to Unsealed Source (radio) Therapy Alan E. Nahum Physics Department Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Wirral CH63 4JY UK alan.nahum@clatterbridgecc.nhs.uk
More informationIMRT Planning Basics AAMD Student Webinar
IMRT Planning Basics AAMD Student Webinar March 12, 2014 Karen Chin Snyder, MS Senior Associate Physicist Department of Radiation Oncology Disclosures The presenter has received speaker honoraria from
More informationApplication of asi-kvcbct for Volume Assessment and Dose Estimation: An Offline Adaptive Study for Prostate Radiotherapy
DOI:10.31557/APJCP.2019.20.1.229 Volume and Dose Assessment on Adapted CT RESEARCH ARTICLE Editorial Process: Submission:08/10/2018 Acceptance:01/05/2019 Application of asi-kvcbct for Volume Assessment
More informationSunCHECK Patient Comprehensive Patient QA
The SunCHECK Platform SunCHECK Patient Comprehensive Patient QA SunCHECK Patient // Comprehensive Patient QA Automate Your Patient QA SunCHECK Patient automates all your Patient QA needs from Secondary
More informationAn update on NTCP data
An update on NTCP data Vladimir Semenenko, Ph.D. X. Allen Li, Ph.D. Department of Radiation Oncology Medical College of Wisconsin NCCAAPM 2006 Fall Meeting, October 3, 2006 Goal of Radiation Therapy Maximize
More information